Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma Meeting Abstract
| Authors: | Lassman, A.; Alexander, B.; Berry, D.; Berry, N.; Buxton, M.; Colman, H.; Gan, H.; de Groot, J.; de la Fuente, M.; Drappatz, J.; Ducray, F.; Ellingson, B.; Gordon, G.; Hyddmark, E.; Johnson, A.; Khasraw, M.; Lee, E.; Lim, M.; McGlothlin, A.; Mellinghoff, I.; Mikkelsen, T.; Nghiemphu, P.; Perry, J.; Powell, A.; Sulman, E.; Tanner, K.; Untch, S.; Weller, M.; Wen, P.; Wick, A.; Yung, A.; Cloughesy, T. |
| Abstract Title: | Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma |
| Meeting Title: | 29th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 26 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2024 Nov 21-24 |
| Meeting Location: | Houston, TX |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-11-01 |
| Start Page: | viii104 |
| End Page: | viii105 |
| Language: | English |
| ACCESSION: | WOS:001362575700033 |
| DOI: | 10.1093/neuonc/noae165.0406 |
| PROVIDER: | wos |
| PMCID: | PMC11553179 |
| Notes: | Meeting Abstract: CTNI-39 (Citation ID: NOAE165.0406) -- Source: Wos |
